TELA Bio, Inc. (TELA)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 20,197 | 18,520 | 18,957 | 16,091 |
| Amortization of intangible assets | 95 | 95 | 95 | 95 |
| Cost of revenue (excluding amortization of intangible assets) | 5,997 | 5,913 | 6,004 | 4,923 |
| Gross profit | 14,105 | 12,512 | 12,858 | 11,073 |
| Sales and marketing | 16,857 | 16,608 | 16,472 | 16,699 |
| Research and development | 2,203 | 2,540 | 2,068 | 2,323 |
| General and administrative | 4,126 | 3,836 | 3,683 | 3,621 |
| Total operating expenses | 23,186 | 22,984 | 22,223 | 22,643 |
| Loss from operations | -9,081 | -10,472 | -9,365 | -11,570 |
| Other income | 379 | 479 | 337 | 301 |
| Interest expense | 1,188 | 1,219 | 1,344 | 1,331 |
| Total other expense, net | -809 | -740 | -1,007 | -1,030 |
| Loss before income tax expense | -9,890 | -11,212 | - | - |
| Income tax expense | 33 | 52 | - | - |
| Net loss | -9,923 | -11,264 | -10,372 | -12,600 |
| Foreign currency translation adjustment | 2 | 1 | 51 | 1 |
| Comprehensive loss | -9,921 | -11,263 | -10,321 | -12,599 |
| Earnings per share, basic | -0.22 | -0.25 | -0.42 | -0.51 |
| Earnings per share, diluted | -0.22 | -0.25 | -0.42 | -0.51 |
| Weighted average number of shares outstanding, basic | 45,365,325 | 45,267,020 | 24,703,578 | 24,663,234 |
| Weighted average number of shares outstanding, diluted | 45,365,325 | 45,267,020 | 24,703,578 | 24,663,234 |